Jack Barkin, MD

North York, Ontario M6A 3B5

0 studies enrolling now · 3 studies all time

What they study most

Prostate Cancer, Prostatic Neoplasms

Studies at this site

• Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
• A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed
• Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure — Completed